CDK1 was associated with maintenance of stem cell properties in lung cancer by interacting with SOX2 [62], another stem cell marker in CRC, and its protein expression increases significantly from normal mucosa to dysplasia and from dysplasia to carcinoma [63,64]. This evidence concerns the gene SOX2 and carcinoma.